• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number S-55-150-120-P6
Device Problem Defective Device (2588)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/27/2020
Event Type  Injury  
Manufacturer Narrative
Estimated date of event.Estimated date of implant.The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no other complaints.The investigation was unable to determine a cause for the reported stent shortening.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.Literature attached: "endoscopic findings of an excessively compressed interwoven nitinol supera stent".
 
Event Description
It was reported through a research presentation titled: "endoscopic findings of an excessively compressed interwoven nitinol supera stent." identifying a 5.5x150mm supera stent.The procedure was to treat a chronic total occlusion of the left superficial femoral artery with severe calcification.The supera stent was deployed without issue.After the stent was released from its sheath, compression of the supera stent was observed on angiography.Subsequently, post-dilatation was performed with a 6.0×150-mm high-pressure non-abbott balloon.Final angiogram and intravascular ultrasound indicated an acceptable result.A week later, the supera stent remained compressed with the appearance of a spider nest.No further treatment was reported.There was no adverse patient effects or clinically significant delay.No additional information was provided.
 
Manufacturer Narrative
This report is being resubmitted to ensure the enclosed attachment can be easily opened by the fda.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA PERIPHERAL STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9963553
MDR Text Key189705173
Report Number2024168-2020-03675
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648226168
UDI-Public08717648226168
Combination Product (y/n)N
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 07/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/15/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Model NumberS-55-150-120-P6
Device Catalogue NumberS-55-150-120-P6
Device Lot Number8073061
Was Device Available for Evaluation? No
Date Manufacturer Received07/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age84 YR
Patient Weight84
-
-